| Dr Roman W Glamb, MD | |
|
888 S King St, Honolulu, HI 96813-3009 | |
| (808) 522-4000 | |
| (808) 522-3361 |
| Full Name | Dr Roman W Glamb |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 49 Years |
| Location | 888 S King St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740386325 | NPI | - | NPPES |
| 04229401 | Medicaid | HI | |
| 00X0046727 | Other | HI | HMSA |
| 6371444 | Other | HI | UHA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD-3592 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Straub Clinic And Hospital | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Straub Clinic And Hospital | 6305759754 | 404 |
News Archive
Senate Republicans target the law's Independent Payment Advisory Board and issue a top-10 list of its biggest problems. Meanwhile, CQ HealthBeat reports on the merits of the "imminent injury" argument that is in play in at least one legal challenge to the law.
The babies of breast cancer patients who undergo chemotherapy while pregnant do not appear to be at higher risk of complications, according to an Article published Online First in The Lancet Oncology.
For the first time, scientists at the Champalimaud Centre for the Unknown, in Lisbon, Portugal, have shown that neuronal cell death in Alzheimer's disease may actually not be a bad thing - on the contrary, it may be the result of a cell quality control mechanism trying to protect the brain from the accumulation of malfunctioning neurons.
Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures. In animal studies, the researchers used the device - a type of electrode array that conforms to the brain's surface - to take an unprecedented look at the brain activity underlying seizures.
The arsenal of prostate cancer treatments for men with advanced prostate cancer may soon be strengthened as the FDA prioritizes the review of both Ra-223 and MDV3100 for treating metastatic castration-resistant prostate cancer (CRPC). Based on positive, independent research of each drug, better survival rates and improved bone health for patients with late-stage prostate cancer may be within reach.
› Verified 2 days ago
| Entity Name | Straub Clinic & Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306508 PECOS PAC ID: 6305759754 Enrollment ID: O20031111000417 |
News Archive
Senate Republicans target the law's Independent Payment Advisory Board and issue a top-10 list of its biggest problems. Meanwhile, CQ HealthBeat reports on the merits of the "imminent injury" argument that is in play in at least one legal challenge to the law.
The babies of breast cancer patients who undergo chemotherapy while pregnant do not appear to be at higher risk of complications, according to an Article published Online First in The Lancet Oncology.
For the first time, scientists at the Champalimaud Centre for the Unknown, in Lisbon, Portugal, have shown that neuronal cell death in Alzheimer's disease may actually not be a bad thing - on the contrary, it may be the result of a cell quality control mechanism trying to protect the brain from the accumulation of malfunctioning neurons.
Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures. In animal studies, the researchers used the device - a type of electrode array that conforms to the brain's surface - to take an unprecedented look at the brain activity underlying seizures.
The arsenal of prostate cancer treatments for men with advanced prostate cancer may soon be strengthened as the FDA prioritizes the review of both Ra-223 and MDV3100 for treating metastatic castration-resistant prostate cancer (CRPC). Based on positive, independent research of each drug, better survival rates and improved bone health for patients with late-stage prostate cancer may be within reach.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roman W Glamb, MD 888 S King St, Straub Department Of Dermatology, Honolulu, HI 96813-3097 Ph: (808) 522-4000 | Dr Roman W Glamb, MD 888 S King St, Honolulu, HI 96813-3009 Ph: (808) 522-4000 |
News Archive
Senate Republicans target the law's Independent Payment Advisory Board and issue a top-10 list of its biggest problems. Meanwhile, CQ HealthBeat reports on the merits of the "imminent injury" argument that is in play in at least one legal challenge to the law.
The babies of breast cancer patients who undergo chemotherapy while pregnant do not appear to be at higher risk of complications, according to an Article published Online First in The Lancet Oncology.
For the first time, scientists at the Champalimaud Centre for the Unknown, in Lisbon, Portugal, have shown that neuronal cell death in Alzheimer's disease may actually not be a bad thing - on the contrary, it may be the result of a cell quality control mechanism trying to protect the brain from the accumulation of malfunctioning neurons.
Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures. In animal studies, the researchers used the device - a type of electrode array that conforms to the brain's surface - to take an unprecedented look at the brain activity underlying seizures.
The arsenal of prostate cancer treatments for men with advanced prostate cancer may soon be strengthened as the FDA prioritizes the review of both Ra-223 and MDV3100 for treating metastatic castration-resistant prostate cancer (CRPC). Based on positive, independent research of each drug, better survival rates and improved bone health for patients with late-stage prostate cancer may be within reach.
› Verified 2 days ago
Dr. Jay L. Grekin, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4360 Fax: 808-522-3361 | |
Bradley S. Lau, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Geoffrey Strider Farnsworth, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Honolulu, HI 96819 Phone: 808-433-6661 | |
Dr. Linda E. Fancher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1010 S King St Ste 220, Honolulu, HI 96814 Phone: 808-597-8038 Fax: 808-596-2387 | |
Janice Matsunaga, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St, Suite 507, Honolulu, HI 96813 Phone: 808-532-0155 Fax: 808-532-0160 | |
Dr. Iris Kimhayoung Noh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4360 | |
Dylan Lee, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1380 Lusitana St Ste 401, Honolulu, HI 96813 Phone: 808-531-7541 Fax: 808-531-7542 |